Psychedelics Today
PT350 – Jim Gilligan – Psilocybin and Accessing the “Off” Switch For Nociplastic Pain
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 1:18:45
- Mas informaciones
Informações:
Sinopsis
In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. www.psychedelicstoday.com
